Pharma Marketing Network

NOVEMBER 1, 2024

The world of pharma marketing is changing rapidly, and 2025 will be no exception. So, what will be the top challenges in 2025, and how can pharma marketers tackle them? This shift includes everything from leveraging social media to engaging patients through apps and personalized email campaigns.

Marketing 52

Marketing Pharma Ethics Healthcare Provider 52

Medico Reach

AUGUST 18, 2022

The healthcare sector has seen a few developments over the years. Tempus began with the goal of incorporating artificial intelligence and data science into the healthcare industry. By leveraging deep research and employing efficient testing techniques, Tempus has managed to help thousands of patients find the correct clinical trials.

Healthcare 98

Healthcare Healthcare Medical Doctors 98

PM360

JULY 13, 2023

During the COVID-19 pandemic, we saw healthcare organizations spend and scramble to implement numerous virtual care point solutions. The global healthcare IT market was valued at $280.3 billion by 2025, growing at a compound annual growth rate of 6.7%. The global healthcare IT market was valued at $280.3

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

Referral MD

MAY 19, 2023

Healthcare is big and regulated. Data breaches can result in fines for healthcare organizations under US and EU privacy and security laws. Healthcare organizations are considering blockchain to secure data due to the value of healthcare data and other international laws governing cloud data storage.

Healthcare 84

Healthcare Healthcare Medical Distribution 84

European Pharmaceutical Review

DECEMBER 19, 2024

1 These concerns are held alongside the promise of this technology and its potential for improving efficiency, enhancing patient outcomes, and addressing critical challenges like staffing shortages. In 2025, organisations must focus on addressing data integrity challenges. Computers in Biology and Medicine. 2024; 177: 108632.

Pharmaceutical 52

Pharmaceutical Ethics Medicine Pharma 52

World of DTC Marketing

JULY 17, 2022

A Harvard study found that almost half of Americans are expected to be obese by 2030, accounting for up to 18 percent of healthcare spending on related conditions, ranging from heart disease and stroke to osteoarthritis. . Novo Nordisk more than doubled its sales targets for obesity drugs to $3.7bn by 2025. Then there is the price.

Side effects 209

Side effects Doctors Insurance Prescription 209

European Pharmaceutical Review

FEBRUARY 28, 2024

The implementation of the EU’s Health Technology Assessment Regulation (HTAR) 1 will play a key role in shaping the patient access pathway for ATMPs such as cell and gene therapies. Currently, these therapies primarily target rare or ultra-rare diseases with small patient populations, which therefore limits clinical study sizes.

Patients 97

Patients Ethics Healthcare Healthcare 97

Contrarian Sales Techniques

OCTOBER 19, 2024

Malaysia’s Budget 2025 is out, on October 18th 2024, and it’s packed with changes that will touch nearly every aspect of your lives and mine, from salaries to taxes, and even our environment. Now, before you celebrate, this change kicks in February 2025, so we have to wait a bit. Boosting Wages (Finally!)

Medical sales 52

Medical sales Medical sales reps Government Ethics 52

European Pharmaceutical Review

AUGUST 1, 2022

The joint Big Data Steering Group of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) has published a third workplan, setting actions to be delivered by 2025. According to EMA, the new plan will further enhance the efficient integration of data analysis into the regulatory evaluation of medicinal products.

Medicine 105

Medicine Networking Electronics Healthcare 105

Prognos Health

NOVEMBER 18, 2021

Datavant , the leader in helping healthcare organizations securely connect their data and a Prognos Health partner, recently held its Future of Health Data Summit in Washington DC. More data should uncover more info about the patient. This includes clinical sensors and devices providing patient-generated data.

Healthcare 52

Healthcare Healthcare Patients Healthcare Provider 52

Nixon Gwilt Law

JULY 12, 2024

The 2025 Medicare Physician Fee Schedule Proposed Rule (the “2025 Proposed Rule”) issued by the Centers for Medicare and Medicaid Services (or “CMS”) on July 10, 2024 contains a number of new policy proposals with significant implications for healthcare innovators.

Physicians 52

Physicians Management Food and Drug Administration Healthcare 52

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. billion deal to acquire Oak Street Health, a value-based primary-care company focused on treating Medicare patients.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarify Health

DECEMBER 3, 2024

The rising cost of healthcare is a perennial challenge for employers and health plans. The average cost of employer-sponsored healthcare is projected to rise 9% in 2025 , higher than the 6.4% increase from the previous year and the highest increase in a decade.

Healthcare 52

Healthcare Healthcare Management Education 52

European Pharmaceutical Review

FEBRUARY 1, 2023

The system includes a public, searchable database for healthcare professionals, patients, and other interested parties. The CTR foresees a three-year transition period, from 2022 to 2025. With CTIS, sponsors can now apply for authorisations in up to 30 EU/EEA countries at the same time and with the same documentation.

Ethics 104

Ethics Government Medicine Healthcare 104

Infuse Medical

DECEMBER 17, 2024

Maintaining high standards of patient care in the healthcare scene of today depends on operational efficiency and exact administration of medical devices. Leading change in these processes is virtual reality (VR), which provides creative ideas for fleet management of medical equipment and operational optimization in healthcare.

Management 52

Management Healthcare Healthcare Training 52

Pharmaceutical Technology

NOVEMBER 1, 2022

Israel, another leading adopter, has a thriving EHR technology industry that is adapting to the country’s widespread use of Big Data from its country’s healthcare systems. In some countries, EHR is deeply integrated into the entire healthcare system. Adoption of EHR data systems.

Electronics 111

Electronics Prescription Healthcare Healthcare 111

European Pharmaceutical Review

OCTOBER 22, 2024

The UK is set to be the first country to introduce a new regulatory framework for innovative products manufactured at or close to the point of patient care, says the Medicines and Healthcare products Regulatory Agency (MHRA). The agency anticipated that the regulation could become law in Summer 2025.

Medicine 89

Medicine Manufacturing Safety Consulting 89

LEVO Health

MAY 7, 2024

Healthcare organizations are increasingly partnering with influencers to build trust with their audience and expand their reach. By collaborating with influencers, healthcare brands can share their message with humanity, connect with consumers personally, and establish credibility within their target communities.

Healthcare 52

Healthcare Healthcare Marketing Healthcare Provider 52

Prognos Health

NOVEMBER 18, 2021

Datavant , the leader in helping healthcare organizations securely connect their data and a Prognos Health partner, recently held its Future of Health Data Summit in Washington DC.

Healthcare 52

Healthcare Healthcare Patients 52

Healthcare Success

OCTOBER 11, 2022

While many affluent consumers don’t think twice about paying cash (or credit) for luxury retail goods, there is a built-in bias that healthcare products and services should be covered by insurance. Generally speaking, today’s healthcare consumers have high expectations. 12 ways to market to and win affluent healthcare consumers.

Healthcare 62

Healthcare Healthcare Marketing Retail 62

European Pharmaceutical Review

MAY 22, 2024

In March, the Medicines and Healthcare products Regulatory Agency (MHRA) approved a new formulation for Xgeva (denosumab) via the agency’s new International Recognition Procedure (IRP). Sandoz stated that it anticipates the biosimilars to launch in Europe from November 2025 at the earliest.

Medicine 98

Medicine Healthcare Healthcare Patients 98

European Pharmaceutical Review

NOVEMBER 23, 2022

The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU).

Medicine 111

Medicine Networking Manufacturing Training 111

LEVO Health

NOVEMBER 30, 2021

As social media continues to increase in popularity with over 4 billion users worldwide, maintaining an online social media presence is essential to your healthcare practice’s digital marketing strategy. By 2025, social commerce sales are expected to reach 79.6 2022 Social Media Marketing Trends. Popularity of Live Streams.

Media 52

Media Healthcare Healthcare Marketing 52

European Pharmaceutical Review

OCTOBER 17, 2024

These factors may increase the likelihood that patients and caregivers carry it regularly. Thus, ARS Pharmaceuticals anticipates approval by Q1 2025 in the UK and launch by summer 2025. What is significant about approval of EURneffy as the first new delivery method in over three decades for adrenaline?

Food and Drug Administration 121

Food and Drug Administration Medicine Consulting Food 121

European Pharmaceutical Review

SEPTEMBER 7, 2022

establishing a multi-stakeholder platform to facilitate the evolution of the clinical trials environment through regular dialogue between all stakeholders, including patients, healthcare professionals and academia.

Medicine 105

Medicine Training Networking Pharmaceutical 105

Medico Reach

AUGUST 30, 2022

After all, healthcare is a sensitive topic for most people, especially racial and ethnic minorities. This adds to the existing obstacles in the healthcare related marketing efforts. New York Presbyterian Hospital’s ‘Patient Stories’. Healthcare advertisements that feature patient experiences can evoke powerful emotions.

Healthcare 52

Healthcare Healthcare Marketing Medical 52

pharmaphorum

SEPTEMBER 29, 2022

A digital patient monitoring tool developed by UK company CyberLiver has been given a breakthrough designation by the FDA for out-of-hospital management of patients with cirrhosis at risk of complications. The post Digital tool cuts hospital readmissions in cirrhosis patients appeared first on.

Patients 52

Patients Management Consulting FDA 52

PM360

JUNE 29, 2022

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer. Reconsider the Role of Packaging.

Retail 97

Retail Marketing Healthcare Healthcare 97

pharmaphorum

DECEMBER 14, 2022

When patients experience intense emotion, either positive or negative, they are rendered unconscious. In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Monopoly money.

Competition 116

Competition FDA Pharmaceutical Marketing 116

Penrod

JANUARY 12, 2024

While this Bulletin was issued at the end of 2022, OCR and the FTC jointly issued a letter to over 130 companies in mid-2023 to notify them of these obligations, drawing widespread notice within the healthcare industry and broader business community. The post Patient Privacy in 2024 appeared first on Penrod.

Patients 52

Patients Healthcare Provider Healthcare Healthcare 52

European Pharmaceutical Review

AUGUST 17, 2022

With our integrated Contract Research, Development, and Manufacturing Organization (CRDMO) platform and proven quality system, we look forward to working with our customers to swiftly deliver their innovative therapies to market in order to save lives and improve healthcare for patients.”.

Manufacturing 96

Manufacturing Pharmaceutical manufacturing Distribution Pharmaceutical 96

Clarify Health

NOVEMBER 21, 2024

Following record healthcare spending of $4.5 trillion in 2024 —of which one-third was classified as wasteful—healthcare systems face mounting pressure to improve efficiency and cut costs without sacrificing quality. This leads to greater staff satisfaction, enhanced morale, and reduced burnout among healthcare professionals.

Healthcare 52

Healthcare Healthcare Leads Medical 52

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. Chief executive officer of Chiesi Group , Marco Vecchia, said: “This addition of the Amryt portfolio, as well as their expertise, will help us on our journey to bring medicines to patients, no matter how rare their condition may be.”. in an all-cash transaction at $14.50

Pharma 98

Pharma Biopharma Management Medicine 98

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. And he has a unique view of how data and health combine. billion in 2021 to $9.23 References.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. billion in 2025. But it is not a simple answer. from 2021 and reach $4.2

Prescription 105

Prescription Medical Patients Side effects 105

pharmaphorum

OCTOBER 12, 2022

He explains that bringing cutting-edge genomic therapies to market which could treat or cure life-threatening diseases can take up to 15 years and cost $2 billion – far too slow to match patients’ needs, and far too expensive on the healthcare system. “We By 2025, pharma’s investment in AI is expected to reach $3 billion.

Medicine 105

Medicine Patients Healthcare Healthcare 105

European Pharmaceutical Review

JUNE 12, 2024

The study included 92 adult patients with confirmed CDI. After treatment, patients were followed up at intervals of 72 hours, three weeks, eight weeks, three months and six months. Safety and quality of life of the patients participating in the study were also assessed. percent of those treated with fidaxomicin.

Safety 111

Safety Patients Side effects Healthcare 111